Class ITerminatedD-600-2013
Drug recall · June 19, 2013
MAXILOSS Weight Advanced recall
Why: Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
MAXILOSS Weight Advanced, 225 mg proprietary blend of herbs, supplied in 36 count capsules in Green & Blue Boxes, Formulated and distributed by Olaax Corp, Lakeland, FL
- Lots / codes
All Lots
- Quantity
- 600 boxes
- Company
- OLAAX International, Bartow, FL
- Distribution
- Nationwide, Puerto Rico and Venezuela and Bolivia
- Initiated
- February 12, 2013 · Voluntary: Firm initiated
- Classified
- June 13, 2013
- Reported
- June 19, 2013
- Ended
- October 1, 2019
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.